Nosocomial and community-acquired spontaneous bacterial peritonitis: Comparative microbiology and therapeutic implications

被引:47
作者
Bert, F
Andreu, M
Durand, F
Degos, F
Galdbart, JO
Moreau, R
Branger, C
Lambert-Zechovsky, N
Valla, D
机构
[1] Hop Beaujon, Dept Microbiol, F-92110 Clichy, France
[2] Hop Beaujon, Dept Hepatol, F-92110 Clichy, France
关键词
D O I
10.1007/s10096-002-0840-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In order to compare the microbiological characteristics of nosocomial and community-acquired episodes of bacterial peritonitis, 95 consecutive, spontaneous episodes were reviewed. Seventy of these episodes were bacteriologically documented. Fifty-three (55.8%) episodes were nosocomial and 42 (44.2%) were community acquired. A total of 78 pathogens were isolated, including 40 gram-positive cocci (34 streptococci, 6 Staphylococcus aureus), 35 gram-negative bacilli (including 23 Escherichia coli), 2 gram-positive bacilli and 1 yeast. Streptococci were found more frequently in community-acquired episodes (53.8%) than in nosocomial episodes (33.3%). Gram-negative bacilli were significantly more frequent in nosocomial episodes than in community-acquired episodes (56.4% vs. 33.3%, P < 0.05). Nosocomial isolates were significantly more resistant to amoxicillin-clavulanic acid (48.7% vs. 18.4%, P < 0.01) and cefotaxime (33.3% vs. 13.2%, P < 0.05) than community-acquired isolates, but no difference was detected regarding resistance to ciprofloxacin. The results indicate that the empirical treatment of spontaneous bacterial peritonitis should differ for nosocomial and community-acquired cases.
引用
收藏
页码:10 / 15
页数:6
相关论文
共 24 条
[1]   SPONTANEOUS BACTERIAL PERITONITIS - AN UPDATE ON EVALUATION, MANAGEMENT, AND PREVENTION [J].
BHUVA, M ;
GANGER, D ;
JENSEN, D .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 (02) :169-175
[2]   A PROSPECTIVE-STUDY OF BACTERIAL-INFECTIONS IN PATIENTS WITH CIRRHOSIS [J].
CALY, WR ;
STRAUSS, E .
JOURNAL OF HEPATOLOGY, 1993, 18 (03) :353-358
[3]   Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: Effect of long-term administration of norfloxacin [J].
Campillo, B ;
Dupeyron, C ;
Richardet, JP ;
Mangeney, N ;
Leluan, G .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1066-1070
[4]  
Chang FY, 1998, INFECT CONT HOSP EP, V19, P328
[5]   Staphylococcus aureus nasal carriage in 104 cirrhotic and control patients - A prospective study [J].
Chapoutot, C ;
Pageaux, GP ;
Perrigault, PF ;
Joomaye, Z ;
Perney, P ;
Jean-Pierre, H ;
Jonquet, O ;
Blanc, P ;
Larrey, D .
JOURNAL OF HEPATOLOGY, 1999, 30 (02) :249-253
[6]   PREVALENCE AND PROGNOSTIC-SIGNIFICANCE OF BACTERASCITES IN CIRRHOSIS WITH ASCITES [J].
CHU, CM ;
CHANG, KY ;
LIAW, YF .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (03) :561-565
[7]   BIOARGOS - A FULLY AUTOMATED BLOOD CULTURE SYSTEM [J].
COURCOL, RJ ;
DUHAMEL, M ;
DECOSTER, A ;
LEMAIRE, VM ;
RASTORGOUEFF, ML ;
OCHIN, D ;
MARTIN, GR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (08) :1995-1998
[8]   NORFLOXACIN PREVENTS SPONTANEOUS BACTERIAL PERITONITIS RECURRENCE IN CIRRHOSIS - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
GINES, P ;
RIMOLA, A ;
PLANAS, R ;
VARGAS, V ;
MARCO, F ;
ALMELA, M ;
FORNE, M ;
MIRANDA, ML ;
LLACH, J ;
SALMERON, JM ;
ESTEVE, M ;
MARQUES, JM ;
DEANTA, MTJ ;
ARROYO, V ;
RODES, J .
HEPATOLOGY, 1990, 12 (04) :716-724
[9]   Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites:: a double-blind randomized trial [J].
Grangé, JD ;
Roulot, D ;
Pelletier, G ;
Pariente, ÉA ;
Denis, J ;
Ink, O ;
Blanc, P ;
Richardet, JP ;
Vinel, JP ;
Delisle, F ;
Fischer, D ;
Flahault, A ;
Amiot, X .
JOURNAL OF HEPATOLOGY, 1998, 29 (03) :430-436
[10]  
Hsieh WJ, 1998, AM J GASTROENTEROL, V93, P962